Behavior Modification, Dentists and Oral Cancer Control

行为矫正、牙医和口腔癌控制

基本信息

  • 批准号:
    7104432
  • 负责人:
  • 金额:
    $ 20.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-08-12 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The hypothesis for this proposal is that the professional behavior of dentists can be modified by strengthening continuing education in oral cancer through a focus on prevention and early detection. The long-range goals are to increase the number of dentists who counsel at-risk patients about tobacco cessation, consistent with Healthy People 2010 objective 3-10c; and to increase the proportion of oral cancers detected at the earliest stage, consistent with Healthy People 2010 objective 21-6. Our project focuses on oral cancer prevention education for practicing dentists in the United States. Key components of oral cancer prevention include risk assessment and risk reduction for tobacco and alcohol use, chemoprevention, early detection and diagnosis. Based on these key components, a standardized continuing education course has been developed and will be presented within each of the ten U.S. Department of Health and Human Service regions. Outcomes assessment methodology has been designed and will be implemented. Prevention and early detection are the focus of this project because despite advances in oral cancer treatment, only about half of all persons diagnosed with oral cancer survive more than five years. Data indicate that the majority of at-risk Americans does not benefit from oral cancer screening from their primary care professionals. Survival rates for those with oral cancer has not significantly changed in the past 20 years, and it has worsened for African American males. The first activity for this fiveyear proposal is a workshop to standardize a continuing education program, with input from oral cancer and tobacco cessation experts and an ADA ad hoe advisory committee. A second workshop will be scheduled to complete the continuing education program, facilitate course coordinator calibration and finalize the outcomes assessment process. Continuing education programs will be conducted nationwide and learning outcomes will be assessed over the fiveyear period. This project will also explore potential for use of the standardized continuing education program for other health care professionals, e.g., dental hygienists, nurse practitioners and primary care physicians.
描述(申请人提供):本提案的假设是 牙医的职业行为可以通过加强 口腔癌的继续教育,重点是预防和早期 侦测长期目标是增加牙医的数量, 建议高危患者戒烟,符合健康 2010年目标3- 10 c;以及增加口腔癌的比例 在最早阶段检测到,符合2010年健康人群目标 21-6.我们的项目侧重于口腔癌预防教育的实践 牙医在美国口腔癌预防的关键组成部分 包括评估和减少吸烟和饮酒风险, 化学预防、早期发现和诊断。根据这些关键 在这方面,已经制定了标准化的继续教育课程, 将在美国卫生和人类健康部的十个部门中提出 服务区域。已经设计了成果评估方法, 实行预防和早期发现是这个项目的重点 因为尽管口腔癌治疗取得了进展, 被诊断患有口腔癌的人存活超过五年。数据 这表明,大多数处于危险之中的美国人并没有从口服避孕药中受益。 癌症筛查从他们的初级保健专业人员。生存率 口腔癌患者在过去20年中没有显著变化, 非裔美国男性的情况更糟本五年的第一项活动 建议是一个标准化继续教育计划的研讨会, 口腔癌和戒烟专家的意见和ADA广告 咨询委员会。将安排第二次讲习班, 继续教育计划,促进课程协调员校准, 完成成果评估进程。继续教育计划将 在全国范围内进行,并在五年内评估学习成果 期该项目还将探讨利用 其他卫生保健标准化继续教育计划 专业人士,例如,牙科医生、执业护士和初级保健 医生

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Influence of continuing education on dental hygienists' knowledge and behavior related to oral cancer screening and tobacco cessation.
  • DOI:
  • 发表时间:
    2013-04
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Walsh;K. Rankin;S. Silverman
  • 通讯作者:
    M. Walsh;K. Rankin;S. Silverman
Oral and pharyngeal cancer control through continuing education.
通过继续教育控制口腔癌和咽癌。
Tobacco cessation education for dentists: an evaluation of the lecture format.
  • DOI:
    10.1007/s13187-010-0042-9
  • 发表时间:
    2010-09
  • 期刊:
  • 影响因子:
    1.6
  • 作者:
    Rankin, Kathleen Vendrell;Jones, Daniel L.;Crews, Karen M.
  • 通讯作者:
    Crews, Karen M.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SOL JR. SILVERMAN其他文献

SOL JR. SILVERMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SOL JR. SILVERMAN', 18)}}的其他基金

Behavior Modification, Dentists and Oral Cancer Control
行为矫正、牙医和口腔癌控制
  • 批准号:
    6781691
  • 财政年份:
    2002
  • 资助金额:
    $ 20.76万
  • 项目类别:
Behavior Modification, Dentists and Oral Cancer Control
行为矫正、牙医和口腔癌控制
  • 批准号:
    6416639
  • 财政年份:
    2002
  • 资助金额:
    $ 20.76万
  • 项目类别:
Behavior Modification, Dentists and Oral Cancer Control
行为矫正、牙医和口腔癌控制
  • 批准号:
    6642787
  • 财政年份:
    2002
  • 资助金额:
    $ 20.76万
  • 项目类别:
Behavior Modification, Dentists and Oral Cancer Control
行为矫正、牙医和口腔癌控制
  • 批准号:
    6932463
  • 财政年份:
    2002
  • 资助金额:
    $ 20.76万
  • 项目类别:
PROFESSIONAL ONCOLOGY EDUCATION PROGRAM
专业肿瘤学教育计划
  • 批准号:
    3451588
  • 财政年份:
    1975
  • 资助金额:
    $ 20.76万
  • 项目类别:
PROFESSIONAL ONCOLOGY EDUCATION PROGRAM
专业肿瘤学教育计划
  • 批准号:
    3451586
  • 财政年份:
    1975
  • 资助金额:
    $ 20.76万
  • 项目类别:
PROFESSIONAL ONCOLOGY EDUCATION PROGRAM
专业肿瘤学教育计划
  • 批准号:
    3451589
  • 财政年份:
    1975
  • 资助金额:
    $ 20.76万
  • 项目类别:
PROFESSIONAL ONCOLOGY EDUCATION PROGRAM
专业肿瘤学教育计划
  • 批准号:
    3451587
  • 财政年份:
    1975
  • 资助金额:
    $ 20.76万
  • 项目类别:

相似海外基金

Cancer Prevention-Interception Against MGUS Progression
癌症预防——阻止 MGUS 进展
  • 批准号:
    10745010
  • 财政年份:
    2023
  • 资助金额:
    $ 20.76万
  • 项目类别:
Colon cancer prevention with non-systemic PDE5 inhibitors
使用非全身性 PDE5 抑制剂预防结肠癌
  • 批准号:
    10484106
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
  • 批准号:
    10512091
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Regulatory Support for Cancer Prevention Agent Development
癌症预防剂开发的监管支持
  • 批准号:
    10676714
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
  • 批准号:
    10683294
  • 财政年份:
    2022
  • 资助金额:
    $ 20.76万
  • 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
  • 批准号:
    10425188
  • 财政年份:
    2021
  • 资助金额:
    $ 20.76万
  • 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
  • 批准号:
    10683047
  • 财政年份:
    2021
  • 资助金额:
    $ 20.76万
  • 项目类别:
Regulatory Support for Cancer Prevention Agent Development
癌症预防剂开发的监管支持
  • 批准号:
    10447553
  • 财政年份:
    2021
  • 资助金额:
    $ 20.76万
  • 项目类别:
Regulatory Support for Cancer Prevention Agent Development
癌症预防剂开发的监管支持
  • 批准号:
    10219786
  • 财政年份:
    2020
  • 资助金额:
    $ 20.76万
  • 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
  • 批准号:
    10223848
  • 财政年份:
    2020
  • 资助金额:
    $ 20.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了